Efalizumab

Revision as of 20:20, 27 September 2011 by WikiBot (talk | contribs) (Protected "Efalizumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Drugbox-mab Efalizumab (Raptiva, Genentech) is a medication used to treat psoriasis, juvenile rheumatoid arthritis, psoriasis, psoriatic arthritis, rheumatoid arthritis. It is a recombinant humanized monoclonal antibody that binds to CD11a and acts as an immunosuppressant. It is administered once weekly by subcutaneous injection.

It acts to inhibit white blood cell migration out of blood vessels into tissues.

Pills  This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.

Template:Immunosuppressants Template:Humanizedmonoclonals

de:Efalizumab

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Efalizumab&oldid=608012"